Sarah Disanto, N.P

NPI: 1043695778
Total Payments
$1,003
2024 Payments
$867.26
Companies
14
Transactions
56
Medicare Patients
267
Medicare Billing
$21,355

Payment Breakdown by Category

Food & Beverage$913.06 (91.0%)
Education$89.99 (9.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $913.06 55 91.0%
Education $89.99 1 9.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Biotech, Inc. $331.90 9 $0 (2024)
ABBVIE INC. $216.69 13 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $138.49 17 $0 (2024)
Ardelyx, Inc. $68.55 4 $0 (2024)
Regeneron Healthcare Solutions, Inc. $42.72 2 $0 (2024)
Ferring Pharmaceuticals Inc. $40.38 2 $0 (2024)
Braintree Laboratories, Inc. $36.79 2 $0 (2024)
PFIZER INC. $25.85 1 $0 (2024)
Gilead Sciences, Inc. $19.84 1 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $19.41 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $867.26 48 Janssen Biotech, Inc. ($310.68)
2023 $85.93 5 ABBVIE INC. ($50.13)
2022 $19.70 1 ABBVIE INC. ($19.70)
2021 $30.16 2 AbbVie Inc. ($16.02)

All Payment Transactions

56 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/18/2024 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $21.47 General
Category: GASTROENTEROLOGY
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $8.26 General
Category: Gastroenterology
12/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $9.60 General
Category: Gastroenterology
12/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $1.22 General
Category: Gastroenterology
11/27/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $3.94 General
Category: Gastroenterology
11/19/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $23.40 General
Category: IMMUNOLOGY
11/12/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $128.63 General
Category: Immunology
11/11/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $18.33 General
Category: GASTROENTEROLOGY
10/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $7.55 General
Category: Gastroenterology
10/16/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $25.65 General
Category: Immunology
10/16/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $6.25 General
Category: Gastroenterology
10/09/2024 Braintree Laboratories, Inc. SUFLAVE (Drug), SUTAB Food and Beverage In-kind items and services $22.65 General
Category: GI COLON PREP
10/09/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $5.19 General
Category: Gastroenterology
10/09/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $4.77 General
Category: Gastroenterology
09/24/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $17.55 General
Category: GI
09/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN, PLENVU Food and Beverage In-kind items and services $3.20 General
Category: Gastroenterology
09/05/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $19.31 General
Category: INFLAMMATION AND IMMUNOLOGY
08/29/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $17.95 General
Category: GASTROENTEROLOGY
08/29/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $1.89 General
Category: GASTROENTEROLOGY
08/14/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $9.54 General
Category: Gastroenterology
08/13/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $19.84 General
07/29/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $19.78 General
Category: GASTROENTEROLOGY
07/17/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $18.27 General
Category: Gastroenterology
07/17/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN, PLENVU Food and Beverage In-kind items and services $14.91 General
Category: Gastroenterology
07/17/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $12.38 General
Category: Gastroenterology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 93 95 $17,554 $5,925
2022 1 30 30 $10,289 $2,696
2021 3 84 84 $23,177 $6,716
2020 2 60 65 $22,255 $6,017
Total Patients
267
Total Services
274
Medicare Billing
$21,355
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 59 61 $6,871 $3,346 48.7%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 23 23 $7,889 $1,977 25.1%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 11 11 $2,794 $601.70 21.5%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 30 30 $10,289 $2,696 26.2%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 46 46 $15,777 $4,036 25.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 24 24 $2,640 $1,423 53.9%
99219 Hospital observation care, typically 50 minutes Facility 2021 14 14 $4,760 $1,257 26.4%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 47 52 $17,835 $4,819 27.0%
99219 Hospital observation care, typically 50 minutes Facility 2020 13 13 $4,420 $1,198 27.1%

About Sarah Disanto, N.P

Sarah Disanto, N.P is a Family healthcare provider based in Geneva, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1043695778.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Disanto, N.P has received a total of $1,003 in payments from pharmaceutical and medical device companies, with $867.26 received in 2024. These payments were reported across 56 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($913.06).

As a Medicare-enrolled provider, Disanto has provided services to 267 Medicare beneficiaries, totaling 274 services with total Medicare billing of $21,355. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Geneva, NY
  • Active Since 07/23/2015
  • Last Updated 07/23/2015
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1043695778

Products in Payments

  • STELARA (Biological) $177.62
  • TREMFYA (Drug) $154.28
  • XIFAXAN (Drug) $134.91
  • RINVOQ (Biological) $102.99
  • IBSRELA (Drug) $68.55
  • LINZESS (Drug) $60.10
  • DUPIXENT (Biological) $42.72
  • SKYRIZI (Biological) $37.58
  • XELJANZ (Drug) $25.85
  • SUFLAVE (Drug) $22.65
  • REBYOTA (Biological) $21.47
  • ENTYVIO (Biological) $19.41
  • CLENPIQ (Drug) $18.91
  • Linzess (Drug) $17.55
  • OMVOH (Drug) $16.46
  • HUMIRA (Biological) $16.02
  • CYLTEZO (Drug) $14.58
  • SUTAB (Drug) $14.14
  • DIFICID (Drug) $13.84
  • TRULANCE (Drug) $3.58

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Geneva